The groundbreaking treatment of tirzepatide peptide represents a major breakthrough in the care of the condition. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – providing improved sugar management and potential weight loss. Researchers are investigating its potent